Aurinia Pharmaceuticals Inc. (AUPH) › Shareholders' EquityAurinia Pharmaceuticals Inc. (AUPH) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2017: $177.92M2018: $135.72M2019: $298.60M2020: $407.75M2021: $479.09M2022: $405.44M2023: $377.95M2024: $377.48M2025: $581.33M$581.33M2017Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$581.33M+54.0%2024$377.48M-0.1%2023$377.95M-6.8%2022$405.44M-15.4%2021$479.09M+17.5%2020$407.75M+36.6%2019$298.60M+120.0%2018$135.72M-23.7%2017$177.92M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share